封面
市场调查报告书
商品编码
1671878

药物释放型支架市场按产品类型、应用、最终用户和地区划分

Drug Eluting Stents Market, By Product Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球药物释放型支架市场规模估计为 84.9 亿美元,预计到 2032 年将达到 152.2 亿美元,2025 年至 2032 年的复合年增长率为 8.7%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 84.9 亿美元
效能资料 从 2020 年到 2024 年 预测期 2025 至 2032 年
预测期:2025-2032年复合年增长率: 8.70% 2032 年价值预测 152.2亿美元
数字。 2025 年药物释放型支架市场占有率(按地区划分)
药物洗脱支架市场-IMG1

由于心血管疾病发病率不断上升以及世界老年人口不断增加,老年人易患冠状动脉疾病和动脉阻塞,全球药物释放型支架市场在过去几年中经历了显着增长。与裸金属支架相比,药物释放型支架因其优点(包括血管再阻塞率较低)越来越受到医师的青睐。此外,支架设计和支架表面药物涂层的技术进步也改善了患者的临床治疗效果。然而,与裸金属支架相比,药物释放型支架的成本较高,这是市场成长的一大障碍。

市场动态:

全球药物释放型支架市场的发展受到老年人口不断增长、心血管疾病负担不断增加以及药物释放型支架相对于裸金属支架的优势(例如血管再阻塞率较低)的推动。然而,与裸金属支架相比,药物释放型支架的成本较高,可能会阻碍市场成长。支架技术和药物涂层的各种发展预计将为市场参与者提供丰厚的机会。例如,生物可吸收药物释放型支架(作用后可在体内溶解)很可能会得到更广泛的应用。同样,开发增强药物分子结合的支架表面可以帮助缩短药物释放型时间并降低治疗成本。

本研究的主要特点

本报告对全球药物释放型支架市场进行了详细分析,并提供了预测期(2025-2032)的市场规模(十亿美元)和年复合成长率(CAGR%),假设 2024 年为基准年。

它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

它根据公司亮点、产品系列、关键亮点、性能和策略等参数,介绍了全球药物释放型支架市场的主要企业概况。

本研究涉及的主要企业包括雅培实验室、波士顿科学公司、美敦力、泰尔茂株式会社、B. Braun Melsungen AG、CR Bard Inc.、库克医疗公司、Biotronik SE &Co.KG、微创科学公司、圣犹达医疗公司(现为雅培的一部分)、强生公司、心血管系统公司、戈尔朝日、Inspire Zire、Hire Zire、Mpire ASAHI INTECC CO., LTD.、Tire。

本报告提供的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。

本研究报告研究了全球药物释放型支架市场,并将其提供给该行业的各个相关人员,例如投资者、供应商、产品製造商、分销商、新进业者和财务分析师。

相关人员可以透过分析全球药物释放型支架市场所使用的各种策略矩阵来促进决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要

第三章市场动态、法规与趋势分析

  • 市场动态
  • 影响分析
  • 主要进展
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • PORTER 分析
  • 併购情景
  • 产业趋势

4. 2020 年至 2032 年全球药物释放型支架市场(按产品类型划分)(十亿美元)

  • 聚合物基涂料
  • 非生物分解的聚合物
  • 生物分解性聚合物
  • 无聚合物涂料
  • 微孔表面
  • 微结构表面
  • 开槽管状表面
  • 奈米多孔表面

5. 全球药物释放型支架市场,按应用划分,2020-2032 年(十亿美元)

  • 冠状动脉疾病
  • 周边动脉疾病
  • 其他的

6. 2020 年至 2032 年全球药物释放型支架市场(以最终用户划分)(十亿美元)

  • 医院
  • 心导管实验室
  • 门诊手术中心
  • 其他的

7. 2020 年至 2032 年全球药物释放型支架市场,按地区划分,价值(十亿美元)

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第八章 竞争格局

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic
  • Terumo Corporation
  • B. Braun Melsungen AG
  • CR Bard Inc.
  • Cook Medical Inc.
  • Biotronik SE & Co. KG
  • MicroPort Scientific Corporation
  • Jude Medical(now part of Abbott)
  • Johnson & Johnson
  • Cardiovascular Systems Inc.
  • Gore Medical
  • InspireMD
  • Asahi Intecc Co., Ltd.
  • Z-Medica

第 9 章分析师建议

第十章参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI566

Global Drug Eluting Stents Market is estimated to be valued at US$ 8.49 Bn in 2025 and is expected to reach US$ 15.22 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: US$ 8.49 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.70% 2032 Value Projection: US$ 15.22 Bn
Figure. Drug Eluting Stents Market Share (%), By Region 2025
Drug Eluting Stents Market - IMG1

The global drug eluting stents market has witnessed significant growth in the past few years owing to the rising prevalence of cardiovascular diseases and increasing geriatric population worldwide who are more prone to coronary heart diseases and artery blockages. Drug eluting stents are increasingly being preferred by physicians over bare metal stents due to advantages such as lower rates of restenosis. Moreover, technological advancements in design of stents and drugs coated on stent surfaces have improved clinical outcomes for patients. However, high costs of drug eluting stents compared to bare metal stents remain a major challenge for market growth.

Market Dynamics:

The global drug eluting stents market is driven by the rising geriatric population, growing burden of cardiovascular diseases, and advantages offered by drug eluting stents over bare metal stents such as lower restenosis rates. However, the high costs of drug eluting stents compared to bare metal stents can hamper the market growth. Various developments in stent technology and drug coatings are expected to present lucrative opportunities for market players. For example, bioabsorbable drug eluting stents that dissolve in the body after performing their action could witness increasing adoption. Likewise, development of stent surfaces that enhance binding of drug molecules could help reduce drug elution times and costs of treatment.

Key Features of the Study:

This report provides in-depth analysis of the global drug eluting stents market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global drug eluting stents market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Terumo Corporation, B. Braun Melsungen AG, C. R. Bard Inc., Cook Medical Inc., Biotronik SE & Co. KG, MicroPort Scientific Corporation, St. Jude Medical (now part of Abbott), Johnson & Johnson, Cardiovascular Systems Inc., Gore Medical, InspireMD, Asahi Intecc Co., Ltd., and Z-Medica

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global drug eluting stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug eluting stents market

Market Segmentation

  • By Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Polymer-based Coatings
    • Non-biodegradable Polymers
    • Biodegradable Polymers
    • Polymer free Coatings
    • Micro porous Surface
    • Micro structured Surface
    • Slotted Tubular Surface
    • Nanoporous Surface
  • By Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Coronary Artery Disease
    • Peripheral Artery Disease
    • Others
  • By End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Cardiac Catheterization Labs
    • Ambulatory Surgical Centers
    • Others
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Medtronic
    • Terumo Corporation
    • B. Braun Melsungen AG
    • C. R. Bard Inc.
    • Cook Medical Inc.
    • Biotronik SE & Co. KG
    • MicroPort Scientific Corporation
    • Jude Medical (now part of Abbott)
    • Johnson & Johnson
    • Cardiovascular Systems Inc.
    • Gore Medical
    • InspireMD
    • Asahi Intecc Co., Ltd.
    • Z-Medica

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Drug Eluting Stents Market, By Product Type
    • Global Drug Eluting Stents Market, By Application
    • Global Drug Eluting Stents Market, By End User
    • Global Drug Eluting Stents Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Drug Eluting Stents Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Polymer-based Coatings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Non-biodegradable Polymers
  • Biodegradable Polymers
  • Polymer free Coatings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Micro porous Surface
  • Micro structured Surface
  • Slotted Tubular Surface
  • Nanoporous Surface

5. Global Drug Eluting Stents Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Coronary Artery Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Peripheral Artery Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Drug Eluting Stents Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cardiac Catheterization Labs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Drug Eluting Stents Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • B. Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • C. R. Bard Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cook Medical Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Biotronik SE & Co. KG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • MicroPort Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Jude Medical (now part of Abbott)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cardiovascular Systems Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Gore Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • InspireMD
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Asahi Intecc Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Z-Medica
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us